- Home
- VUZI vs SCPH Comparison
VUZI vs SCPH Comparison
Compare VUZI & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VUZI
- SCPH
- Stock Information
- Founded
- VUZI 1997
- SCPH 2013
- Country
- VUZI United States
- SCPH United States
- Employees
- VUZI N/A
- SCPH N/A
- Industry
- VUZI Industrial Machinery/Components
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- VUZI Technology
- SCPH Health Care
- Exchange
- VUZI Nasdaq
- SCPH Nasdaq
- Market Cap
- VUZI 167.7M
- SCPH 173.6M
- IPO Year
- VUZI N/A
- SCPH 2017
- Fundamental
- Price
- VUZI $2.31
- SCPH $5.58
- Analyst Decision
- VUZI
- SCPH Buy
- Analyst Count
- VUZI 0
- SCPH 3
- Target Price
- VUZI N/A
- SCPH $12.00
- AVG Volume (30 Days)
- VUZI 1.2M
- SCPH 2.2M
- Earning Date
- VUZI 08-14-2025
- SCPH 08-07-2025
- Dividend Yield
- VUZI N/A
- SCPH N/A
- EPS Growth
- VUZI N/A
- SCPH N/A
- EPS
- VUZI N/A
- SCPH N/A
- Revenue
- VUZI $5,534,768.00
- SCPH $49,969,000.00
- Revenue This Year
- VUZI $22.67
- SCPH $108.95
- Revenue Next Year
- VUZI $80.00
- SCPH $78.30
- P/E Ratio
- VUZI N/A
- SCPH N/A
- Revenue Growth
- VUZI N/A
- SCPH 107.79
- 52 Week Low
- VUZI $0.85
- SCPH $1.94
- 52 Week High
- VUZI $5.79
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- VUZI 55.52
- SCPH 63.23
- Support Level
- VUZI $1.83
- SCPH $4.33
- Resistance Level
- VUZI $2.18
- SCPH $5.62
- Average True Range (ATR)
- VUZI 0.13
- SCPH 0.13
- MACD
- VUZI 0.05
- SCPH 0.04
- Stochastic Oscillator
- VUZI 66.68
- SCPH 96.51
About VUZI Vuzix Corporation
Vuzix Corp is engaged in the design, manufacture, and marketing of Artificial Intelligence (AI)-powered Smart Glasses, Waveguides, and Augmented Reality (AR) technologies. Its solutions serve the enterprise, medical, defense, security, and select consumer markets, offering cutting-edge wearable computing and display technologies that enhance productivity and operational efficiency. Its products include near-eye displays (NEDs), heads-up displays (HUDs), and wearable computing devices. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, the Netherlands, and other countries.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.